A Randomized, Double-blind, Multicenter Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy in Comparison With Fimasartan Monotherapy for Essential Hypertension Patients Not Controlled by Fimasartan 60mg (Phase 3).

Trial Profile

A Randomized, Double-blind, Multicenter Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy in Comparison With Fimasartan Monotherapy for Essential Hypertension Patients Not Controlled by Fimasartan 60mg (Phase 3).

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Dec 2016

At a glance

  • Drugs Fimasartan/hydrochlorothiazide (Primary) ; Fimasartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jun 2013 Primary endpoint 'Diastolic-blood-pressure' has been met.
    • 13 Jun 2013 Results presented at the 23rd European Meeting on Hypertension.
    • 04 Jan 2012 Actual patient number (263) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top